Hughes G F, McElnay J C, Hughes C M, McKenna P
School of Pharmacy, Queen's University of Belfast, Medical Biology Centre, Northern Ireland.
Pharm World Sci. 1999 Dec;21(6):251-5. doi: 10.1023/a:1008788726842.
To investigate the abuse of non-prescription (over-the-counter; OTC) products in Northern Ireland.
A structured questionnaire covering various aspects of OTC drug abuse was mailed to all 509 community pharmacies in Northern Ireland.
253 responses were received (response rate 49.7%) after two mailings. Pharmacists named 112 OTC products they perceived were being abused in Northern Ireland. These were classified into 8 groups, with opioids, antihistamines and laxatives the most frequently reported. The frequency of abuse of all product groups was perceived to be either increasing or static. The number of clients suspected of abuse over a three-month period ranged from 0 to 700 (median = 10, mode = 6) with 55% being regular customers. Pharmacists employed several methods to limit patient access to products of abuse. The most common technique was to keep the product out of sight. Others included additional client questioning, providing advice and limiting the quantity of product sold. The majority of respondents agreed their role could be extended to include other methods of dealing with abusers, including participation in harm-reduction programmes to wean abusers off products. Geographical region and location of pharmacy were not significant factors in the abuse of OTC products.
Pharmacists in Northern Ireland perceive abuse and misuse of OTC products to be occurring in practice. Current methods employed for dealing with it are inadequate. Research into methods of effectively dealing with OTC abuse/misuse is required and has commenced on the basis of these findings.
调查北爱尔兰非处方(非处方药;OTC)产品的滥用情况。
向北爱尔兰所有509家社区药房邮寄了一份涵盖非处方药滥用各个方面的结构化问卷。
经过两次邮寄后,共收到253份回复(回复率49.7%)。药剂师列出了他们认为在北爱尔兰正被滥用的112种非处方产品。这些产品被分为8组,其中阿片类药物、抗组胺药和泻药是报告频率最高的。所有产品组的滥用频率被认为要么在增加,要么保持不变。在三个月期间,被怀疑滥用的客户数量从0到700不等(中位数 = 10,众数 = 6),其中55%是常客。药剂师采用了几种方法来限制患者获取滥用产品。最常见的方法是将产品放在看不见的地方。其他方法包括对客户进行额外询问、提供建议以及限制产品销售量。大多数受访者同意他们的角色可以扩展到包括处理滥用者的其他方法,包括参与减少伤害计划以使滥用者戒除产品。地理区域和药房位置不是非处方产品滥用的重要因素。
北爱尔兰的药剂师认为在实际中存在非处方产品的滥用和误用情况。目前用于处理该问题的方法并不充分。需要对有效处理非处方滥用/误用的方法进行研究,并且已基于这些发现展开研究。